Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Top 5 NASDAQ Genetics Stocks (Updated December 2023)

Apr 05, 2023

Top 5 NASDAQ Genetics Stocks (Updated March 2023)

Press Releases

Jun 04, 2026

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors

May 29, 2026

Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds

May 14, 2026

Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

See More Press Releases

The Conversation (0)

Alert Options

No alert set

INN Article Notification

Instant Daily Weekly

Alert Option

You will be notified when this event occurs. No additional settings needed.